EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC 4.0

Deprescribing trials need a rationale-first framework before choosing trial design

Catherine S Hwang, Kenneth S Boockvar, Michael A Steinman

The Lancet Healthy Longevity · 2026-08 · 7 (8) · 100893

DOI: 10.1016/j.lanhl.2026.100893 ↗

Kurz gefasst

Leserbrief in der Zeitschrift The Lancet Healthy Longevity, 2026-08. Verfasst von Catherine S Hwang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR 97239, USA; Section of General Internal Medi…. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: VHA National Center for Patient Safety Washington, National Institutes of Health.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of General Internal Medicine and Geriatrics, Oregon Health and Science University, Portland, OR 97239, USA; Section of General Internal Medicine, VA Portland Health Care System, Portland, OR, USA. Electronic ad…
  • Division of Gerontology, Geriatrics, and Palliative Care, University of Alabama at Birmingham, AL, USA; Geriatrics Research, Education, and Clinical Center, VA Birmingham Health Care System, Birmingham, AL, USA.
  • Division of Geriatrics, University of California, San Francisco, San Francisco, CA, USA; Section of Geriatrics and Extended Care, VA San Francisco Health Care System, San Francisco, CA, USA.

Förderung

  • VHA National Center for Patient Safety Washington
  • National Institutes of Health

Zitieren

APA

Hwang, C. S., Boockvar, K. S., & Steinman, M. A. (2026). Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity, 7(8), 100893. https://doi.org/10.1016/j.lanhl.2026.100893

Vancouver

Hwang CS, Boockvar KS, Steinman MA. Deprescribing trials need a rationale-first framework before choosing trial design. The Lancet Healthy Longevity. 2026;7(8):100893. doi:10.1016/j.lanhl.2026.100893

BibTeX
@article{Hwang2026,
  author = {Hwang, Catherine S and Boockvar, Kenneth S and Steinman, Michael A},
  title = {Deprescribing trials need a rationale-first framework before choosing trial design},
  journal = {The Lancet Healthy Longevity},
  year = {2026},
  volume = {7},
  number = {8},
  pages = {100893},
  doi = {10.1016/j.lanhl.2026.100893}
}
Kostenlos starten →